previous compound ID: 993 next compound
InChIKey: IRSCQMHQWWYFCW-UHFFFAOYSA-N
SMILES: C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Goepp" "DY Thomas" "GW Carlile" "B Kus" "E Matthes" "SD Macknight" "D Rotin" "J Liao" "R Robert" "JW Hanrahan"

chemical graph of compound 993





CID is 3454
synonyms found at PubChem are:
ganciclovir, 82410-32-0, Gancyclovir, Cytovene, Vitrasert, Hydroxyacyclovir, Ganciclovirum, Zirgan, RS-21592, Cymevene, HHEMG, Biolf 62, BW-759U, Ganciclovirum [Latin], 2'-NDG, 2-Amino-9-(((1,3-dihydroxypropan-2-yl)oxy)methyl)-1H-purin-6(9H)-one, BW 759U, 2'-Nor-2'-deoxyguanosine, BIOLF-62, Citovirax, Cymevan, Cymeven, 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine, Virgan, BW-B 759U, Cytovene-IV, UNII-P9G3CKZ4P5, DRG-0018, Vitrasert (TN), BW 759, Cytovene (TN), 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one, CCRIS 9212, GA2, HSDB 6512, 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine, 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine, Ganciclovir [USAN:INN:BAN:JAN], IN1478, 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE, GCV & MSL, P9G3CKZ4P5, Ganciclovir (JAN/USP/INN), MLS000028481, Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-, CHEBI:465284, 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol, Natclovir, 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one, 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one, BW-795, MB3795, ST-605, 6H-Purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-, GCV & 1110U81, Cytovene IV, NCGC00015471-02, SMR000058324, 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one, CAS-82410-32-0, 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one, G 2536, DSSTox_CID_21032, DSSTox_RID_79613, DSSTox_GSID_41032, 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol, 2-(2-Amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol, 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one, 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one, 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone, 2-amino-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-3H-purin-6-one, 2-amino-9-(((1,3-dihydroxypropan-2-yl)oxy)methyl)-1,9-dihydro-6H-purin-6-one, CPD000058324, SR-01000075894, 9-[[2-Hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine, denosine, 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-1H-purin-6-one, 2-amino-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-1H-purin-6-one, Ganciclovir,(S), Cymevene (TN), Prestwick_1068, Zirgan (TN), Ganciclovir [USAN:USP:INN:BAN:JAN], Opera_ID_284, Prestwick0_000839, Prestwick1_000839, Prestwick2_000839, Prestwick3_000839, Lopac-G-2536, CHEMBL182, D01LAP, D05ARP, EC 627-054-3, AC1L1FZ2, AC1Q52OB, SCHEMBL3033, Lopac0_000539, BSPBio_000797, ISIS 2922 + Ganciclovir, MLS001077349, BIDD:GT0783, SPBio_002718, BPBio1_000877, ZINC1505, DTXSID8041032, methyl)-1H-purin-6(9H)-one, SCHEMBL14491348, BDBM85707, CTK8A1866, CTK8B5009, KS-00000JPM, Ganciclovir & D5-dgA immunotoxin, IRSCQMHQWWYFCW-UHFFFAOYSA-N, MolPort-000-758-398, MolPort-002-507-301, MolPort-006-167-681, HMS1570H19, HMS2090K08, HMS2097H19, HMS2235C21, HMS3259B13, HMS3261L19, HMS3371H01, HMS3604L19, HMS3655M18, HMS3714H19, Pharmakon1600-01502362, ACT03317, BCP12705, Ganciclovir & C34-dgA immunotoxin, NSC_3454, Tox21_110160, Tox21_500539, ANW-47031, BBL029078, MFCD00870588, NSC759656, PDSP1_000816, PDSP2_000803, s1878, SBB066292, STK801910, AKOS004119898, AKOS026749928, Tox21_110160_1, AC-8069, AN-5258, CCG-204629, CS-2014, DB01004, Ganciclovir, >=99% (HPLC), powder, KS-1065, LP00539, MCULE-9512761592, NC00647, NE60398, NSC-759656, SMP2_000038, NCGC00015471-01, NCGC00015471-03, NCGC00015471-04, NCGC00015471-05, NCGC00015471-06, NCGC00015471-08, NCGC00093928-01, NCGC00093928-02, NCGC00168567-01, NCGC00188980-01, NCGC00261224-01, 9-(1,3-dihydroxy-2propoxymethyl)guanine, AJ-08038, AN-14719, HY-13637, LS-73939, SAM002548936, SAM002589952, SC-12208, ZB000351, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, 107910-75-8 (mono-hydrochloride salt), AB0012496, AB2000347, CAS_82410-32-0, 2-amino-9-((1,3-dihydroxypropan-2-yloxy), 9-(1,3-dihydroxy-2-propoxymethyl)-guanine, EU-0100539, FT-0611007, G0315, EN300-49857, C07019, D00333, J10127, 40034-EP2377510A1, 410G320, A840322, Ganciclovir, Antibiotic for Culture Media Use Only, SR-01000721941, I07-0010, Q-201148, SR-01000075894-1, SR-01000075894-4, SR-01000721941-3, Z1259084907, Ganciclovir, European Pharmacopoeia (EP) Reference Standard, 2-azanyl-9-[1,3-bis(oxidanyl)propan-2-yloxymethyl]-3H-purin-6-one, Ganciclovir, United States Pharmacopeia (USP) Reference Standard, 2-amino-9-{[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl}hydropurin-6-one, Ganciclovir, Pharmaceutical Secondary Standard; Certified Reference Material, 2-amino-9-(((1,3-dihydroxypropan-2-yl)oxy)methyl)-3,9-dihydro-6H-purin-6-one, Ganciclovir, 1.0 mg/mL (1% 1M HCl in Methanol), certified reference material, 106931-35-5, 86357-12-2, 96551-29-0, Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)- and MSL, neutralizing monoclonal antibody, Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody